Johnson & Johnson Early Career Innovator Award supports early-career investigators’ innovative research on inflammatory skin disorders to deepen understanding and strengthen prospects for NIH funding.
Funder: Dermatology Foundation
Due Dates: December 1, 2026 (Applications) | January 1, 2027 (Renewals)
Funding Amounts: $100,000 annually for up to three years, as described in the 2026 instructions
Summary: Supports early-career investigators conducting innovative basic, clinical, or translational research on inflammatory skin disorders.
Key Information: Applicants need at least one year of DF CDA or similar funding, or a DF CDA returned upon receiving federal funding.
The Dermatology Foundation administers this award with support from Johnson & Johnson to advance research on inflammatory skin disorders. It supports outstanding early-career investigators developing a track record of excellence in basic, clinical, or translational science. Funded projects are expected to produce innovative findings that deepen understanding of dermatological issues associated with inflammatory skin conditions.
The award is intended to help investigators with prior career development funding strengthen their ability to compete for NIH R01 awards. The Foundation encourages applications from minority populations and research addressing health issues affecting racial minorities, sexual and gender/LGBTQ minorities, and underserved or disadvantaged communities. The application instructions describe hypothesis-driven projects spanning three years and an expectation that applicants actively pursue NIH funding.